Bank of Montreal
AGTC

Bank of Montreal’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bank of Montreal’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,358
Closed -$11K – 5329
2021
Q1 		$11K Sell
2,358
-2,172
-48% -$11.3K ﹤0.01% 4352
2020
Q4 		$21K Sell
4,530
-9,598
-68% -$47.1K ﹤0.01% 4408
2020
Q3 		$76K Sell
14,128
-738
-5% -$4.03K ﹤0.01% 3238
2020
Q2 		$90K Buy
14,866
+8,866
+148% +$40.6K ﹤0.01% 3146
2020
Q1 		$19K Buy
+6,000
New +$31.6K ﹤0.01% 3278
2019
Q4 		– Sell
-575
Closed -$2K – 5076
2019
Q3 		$2K Sell
575
-1,309
-69% -$4.73K ﹤0.01% 4656
2019
Q2 		$7K Hold
1,884
– – ﹤0.01% 4634
2019
Q1 		$8K Sell
1,884
-8
-0.4% -$28 ﹤0.01% 3948
2018
Q4 		$5K Buy
1,892
+12
+0.6% +$70 ﹤0.01% 4116
2018
Q3 		$14K Sell
1,880
-3,181
-63% -$13.9K ﹤0.01% 3831
2018
Q2 		$19K Sell
5,061
-24
-0.5% -$111 ﹤0.01% 3764
2018
Q1 		$20K Sell
5,085
-14,375
-74% -$60.4K ﹤0.01% 3563
2017
Q4 		$70K Sell
19,460
-38,642
-67% -$146K ﹤0.01% 3145
2017
Q3 		$230K Sell
58,102
-1,296
-2% -$5.95K ﹤0.01% 2617
2017
Q2 		$302K Buy
59,398
+2,666
+5% +$15K ﹤0.01% 2472
2017
Q1 		$392K Buy
56,732
+17,481
+45% +$137K ﹤0.01% 2190
2016
Q4 		$360K Sell
39,251
-2,329
-6% -$21K ﹤0.01% 2243
2016
Q3 		$406K Buy
41,580
+1,514
+4% +$20.4K ﹤0.01% 2167
2016
Q2 		$565K Buy
40,066
+8,162
+26% +$127K ﹤0.01% 2072
2016
Q1 		$446K Buy
31,904
+8,823
+38% +$129K ﹤0.01% 2093
2015
Q4 		$471K Buy
23,081
+1,226
+6% +$18.9K ﹤0.01% 2019
2015
Q3 		$287K Sell
21,855
-1,270
-5% -$21.1K ﹤0.01% 2097
2015
Q2 		$355K Buy
23,125
+22,275
+2,621% +$427K ﹤0.01% 2146
2015
Q1 		$17K Buy
+850
New +$19K ﹤0.01% 3323

Other funds holding AGTC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Bank of Montreal's AGTC Position: Q2 2021 in Review

Bank of Montreal sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 2,358 shares — an estimated $11K sold.

Bank of Montreal first reported a position in AGTC in Q1 2015 and held it in 24 quarters. The position peaked at $565K in Q2 2016. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • Bank of Montreal reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,358 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $11K.
  • Bank of Montreal first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 24 quarters.
  • Bank of Montreal's Applied Genetic Technologies Corporation position peaked at $565K in Q2 2016.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.